高级检索
当前位置: 首页 > 详情页

Long-term survival outcomes of esophageal squamous cell carcinoma with intraoperative thoracic duct ligation: a large-scale propensity score matching analysis

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]Univ Elect Sci & Technol China, Sichuan Canc Hosp & Inst, Sichuan Canc Hosp, Sichuan Clin Res Ctr Canc,Affiliated Canc Hosp,Dep, Chengdu, Sichuan, Peoples R China [2]Kunming Med Univ, Yunnan Tumor Hosp, Dept Thorac & Cardiovasc Surg, Affiliated Hosp 3, Kunming, Peoples R China [3]Chongqing Med Univ, Sch Publ Hlth, Chongqing, Peoples R China [4]Zigong First peoples Hosp, Dept Thorac Surg, Zigong, Sichuan, Peoples R China [5]Univ Elect Sci & Technol China UESTC, Sichuan Canc Hosp & Inst, Dept Radiat Oncol, Chengdu, Peoples R China [6]Radiat Oncol Key Lab Sichuan Prov, Chengdu, Peoples R China
出处:
ISSN:

关键词: esophageal squamous cell carcinoma intraoperative thoracic duct ligation esophagectomy overall survival propensity score matching

摘要:
Background Esophagectomy is the primary treatment for localized esophageal squamous cell carcinoma (ESCC). Intraoperative thoracic duct ligation (TDL) has been suggested as an adjunct to reduce the risk of postoperative chylothorax in patients with ESCC, but its effect on long-term oncologic outcomes remains uncertain.Methods Data from the Sichuan Cancer Hospital and Institute Esophageal Cancer Case Management Database were analyzed for patients treated between 2010 and 2017. Participants were classified into TDL and non-TDL groups. Univariate Cox regression analyses and propensity score matching (PSM) were used to identify independent risk factors for overall survival (OS).Results A total of 2,510 patients were included, with 2,095 in the TDL group and 415 in the non-TDL group. The median follow-up was 63.97 months. No significant differences in OS were observed between the TDL and non-TDL groups (HR: 1.13; 95% CI: 0.96-1.31; P = 0.13). After PSM, the analysis continued to show no significant differences between the groups (P = 0.72).Conclusion Intraoperative TDL during esophagectomy did not significantly impact long-term OS in patients with ESCC.

基金:
语种:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2025]版:
大类 | 3 区 医学
小类 | 4 区 肿瘤学
最新[2025]版:
大类 | 3 区 医学
小类 | 4 区 肿瘤学
JCR分区:
出版当年[2025]版:
最新[2023]版:
Q2 ONCOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2024版] 出版当年五年平均 出版前一年[2024版]

第一作者:
第一作者机构: [1]Univ Elect Sci & Technol China, Sichuan Canc Hosp & Inst, Sichuan Canc Hosp, Sichuan Clin Res Ctr Canc,Affiliated Canc Hosp,Dep, Chengdu, Sichuan, Peoples R China [2]Kunming Med Univ, Yunnan Tumor Hosp, Dept Thorac & Cardiovasc Surg, Affiliated Hosp 3, Kunming, Peoples R China
共同第一作者:
通讯作者:
推荐引用方式(GB/T 7714):
APA:
MLA:

相关文献

[1]Surgical vs nonsurgical treatment for esophageal squamous cell carcinoma in patients older than 70 years: a propensity score matching analysis [2]Long-term outcomes of intrathoracic vs. cervical anastomosis post-esophagectomy: a large-scale propensity score matching analysis [3]A propensity-score matching analysis comparing long-term survival of surgery alone and postoperative treatment for patients in node positive or stage III esophageal squamous cell carcinoma after R0 esophagectomy [4]Development and validation of a predictive model for overall survival in esophageal squamous cell carcinoma post-esophagectomy: the role of lymph node metastatic Stations [5]Sunitinib combined with transarterial chemoembolization versus transarterial chemoembolization alone for advanced-stage hepatocellular carcinoma: a propensity score matching study [6]Effect of cervical paraesophageal lymph node metastasis versus supraclavicular lymph node metastasis on the overall survival of patients with thoracic esophageal squamous cell carcinoma: an observational study [7]Effect of Cervical Paraesophageal Lymph Node Metastasis Versus Supraclavicular Lymph Node Metastasis on the Overall Survival of Patients With Thoracic Esophageal Squamous Cell Carcinoma: An Observational Study [8]基于倾向性评分匹配的食管鳞癌新辅助放化疗和术后辅助放化疗的疗效比较 [9]局部晚期食管鳞状细胞癌患者新辅助化疗联合免疫和新辅助放化疗的病理反应和生存结果的比较:倾向评分匹配分析 [10]Comparison of pathologic response and survival outcomes between neoadjuvant chemoradiotherapy (nCRT) and neoadjuvant immunochemotherapy (nICT) in patients with locally advanced esophageal squamous cell carcinoma: a propensity score-matched analysis

资源点击量:56486 今日访问量:0 总访问量:4732 更新日期:2025-04-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 四川省肿瘤医院 技术支持:重庆聚合科技有限公司 地址:成都市人民南路四段55号